Nasdaq-listed insurer Global Indemnity is likely to come under strong pressure from investors to sell by year-end given that its majority private equity backer has already had two extensions of the fund that holds the investment.
Nasdaq-listed insurer Global Indemnity is likely to come under strong pressure from investors to sell by year-end given that its majority private equity backer has already had two extensions of the fund that holds the investment.